PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Steven Mark Taylor, MD, FRCS(C), FACS - Beyond Face Value: The Case for Considering Immunotherapy in Locally Advanced cSCC
Visit https://www.peervoice.com/BAR860 to view the entire programme with slides. After completing “Steven Mark Taylor, MD, FRCS(C), FACS - Beyond Face Value: The Case for Considering Immunotherapy in Locally Advanced cSCC”, participants will be able to: Illustrate key patient and disease characteristics that may prompt consideration of immunotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC); Evaluate the latest evidence with immunotherapy for cSCC; and Describe the multidisciplinary collaboration required to optimize outcomes for patients with cSCC.